Product Description: Pimivalimab (JTX-4014) is a PD-1 inhibitor. Pimivalimab can be used for the research of solid tumor[1].
Applications: Cancer-programmed cell death
Formula: N/A
References: [1]K. Papadopoulos, et al. 172P Phase I study of JTX-8064, a LILRB2 (ILT4) inhibitor, as monotherapy and combination with pimivalimab (pimi), a PD-1 inhibitor (PD-1i), in patients (pts) with advanced solid tumors. VOLUME 16, SUPPLEMENT 1, 100284, DECEMBER 01, 2022.
CAS Number: 2293951-22-9
Molecular Weight: N/A
Research Area: Cancer
Solubility: 10 mM in DMSO
Target: PD-1/PD-L1